January 1, 2010

FDA issues notice regarding the Steris System 1 processor

By: OR Manager
Share

The Food and Drug Administration (FDA) in a December 3, 2009 notice outlined regulatory concerns about the Steris System 1 processor and recommended that facilities make a transition to alternative products as soon as possible.

In the notice, the FDA says Steris has “significantly modified” the Steris System 1 over a number of years without FDA approval or clearance. Thus, the FDA says it “has not determined whether the product is safe or effective for its labeled claims, including claims that it sterilizes medical devices.”

Steris System 1 is a low-temperature reprocessing system that uses a per-acetic acid solution for devices like endoscopes that can be immersed. The FDA recommends that facilities using the Steris System 1:

  • make a transition to an alternative method as soon as possible
  • if they don’t have an acceptable alternative now, take steps to acquire “legally marketed substitutes.”

The FDA said it has received some reports of malfunctions that have the potential to contribute “to serious injuries to patients, such as infections” but did not describe specific malfunctions nor provide evidence of any infections. It also said there have been reports of staff injuries, mostly burns from exposure to the sterilant.

Steris, in a December 4, 2009, statement, said it disagrees with the FDA notice and considers System 1 to be “safe and effective when used as directed.” The company said it is working to engage the FDA in further dialogue.

FDA warning letter

The FDA activity dates to a 2008 warning letter it sent to Steris about modifications the FDA said could “significantly affect the safety or effectiveness of the device” and for which it said Steris should have made 510(k) submissions.

Steris said it submitted a new 510(k) to the FDA on January 5, 2009. Steris also said it notified customers at that time that it would discontinue sales in the US of the System 1 processor that is the subject of the warning letter, except for product replacements. The company said it would continue to support existing System 1 processors for at least 2 years, including selling accessories and the sterilant, providing service and parts, and selling replacement units on a one-for-one basis.

In the December 3 notice, the FDA said that based on a recent inspection and meetings with Steris, the agency is not satisfied that the company has been working effectively to transition its customers to replacements.

What if a facility keeps using System 1?

The FDA said it does not expect to take action against facilities solely because they are using System 1, the agency said in questions and answers accompanying the notice. It reminds facilities that under medical device reporting rules, they are required to report suspected device-related deaths and serious injuries to the FDA and to the manufacturer as well as to report serious injuries to the manufacturer or to the FDA if the manufacturer is unknown.?

The FDA notice is at www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm191585.htm

The Steris statement is at www.steris.com/about/news/

Join our community

Learn More
Video Spotlight
Live chat by BoldChat